article
The success of CAR-Ts in oncology has stoked enthusiasm for…
2 October 2024 | By Ibon Garitaonandia (CellProthera)
The success of CAR-Ts in oncology has stoked enthusiasm for developing comparable curative therapies in other disease areas. CellProthera’s Chief Scientific Officer, Ibon Garitaonandia, explains the potential and progress for CGTs in cardiology, where disease-modifying therapies are largely non-existent.